ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

University of Pisa at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

University of Pisa takes part in 4 sessions at ESMO 2026 in Madrid. Its work focuses on later-line treatment and treatment selection in metastatic colorectal cancer. It covers targeted drug combinations, including treatment guided by circulating tumor DNA in cancers with a specific mutation.

OrganizationESMO 2026 Attendance
University & institute
Public university in Pisa, Italy, with a school of medicine linked to the city's university hospital.
Talk
Sat Oct 24
10:30–10:45
Metastatic colorectal cancer: Discussion
ESMO Clinical Practice Guidelines 1
Gastrointestinal cancersGynaecological cancers
Satellite
Sat Oct 24
13:40–14:00
Extending the continuum of care: Advances in later line treatment for mCRC
Merck Healthcare KGaA - Striving for more: The cutting edge of therapeutic developments in mCRC
Gastrointestinal cancers

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at University of Pisa

Tell us what you sell and we’ll find the people at University of Pisa most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction